Eli Lilly and Co. v. Revlon, Inc.

577 F. Supp. 477, 223 U.S.P.Q. (BNA) 251
CourtDistrict Court, S.D. New York
DecidedDecember 8, 1983
Docket83 Civ. 8504(RWS)
StatusPublished
Cited by20 cases

This text of 577 F. Supp. 477 (Eli Lilly and Co. v. Revlon, Inc.) is published on Counsel Stack Legal Research, covering District Court, S.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Eli Lilly and Co. v. Revlon, Inc., 577 F. Supp. 477, 223 U.S.P.Q. (BNA) 251 (S.D.N.Y. 1983).

Opinion

SWEET, District Judge.

Plaintiffs Eli Lilly and Company (“Eli Lilly”) and its subsidiary Elizabeth Arden, Inc. (“Arden”) commenced this action on November 22, 1983 against defendant Revlon, Inc. (“Revlon”) claiming a violation of § 43(a) of the Trademark Act of 1946, as amended, 15 U.S.C. § 1125(a), infringement of common law trademark and unfair competition. Eli Lilly and Arden now seek a preliminary injunction against the use of the notation “lip repair cream” in connection with the advertisement, offering for sale or distribution of Revlon’s lip treatment cream which is scheduled to be shipped to customers nationwide on December 12, 1983. The parties appeared before this court for an evidentiary hearing and oral argument on December 6, 1983. For *480 the following reasons, plaintiffs’ motion for a preliminary injunction is denied.

Prior Proceedings

Eli Lilly and Arden commenced the action on November 22, 1983 and obtained an order to show cause setting November 29 as a hearing date for their motion for preliminary injunction. The Honorable Richard Owen to whom the action was assigned, recused himself on November 22. The parties stipulated to a one-week adjournment of the hearing on the motion to December 6. The action was reassigned on December 1, 1983, and the hearing went forward on December 6, the adjourned date. Affidavits and memoranda were submitted and four witnesses testified. No discovery has taken place.

The court has been greatly assisted by the careful and cogent presentation of counsel for both parties which has served to simplify the issues in this multimillion dollar dispute between two leading companies in the beauty aid industry. While the issues may merit a more detailed treatment than that which follows, the exigencies of time resulting from Revlon’s December 12 launch date and the reviewability of the District Court’s decision in actions such as this mandate this early decision. 1

Facts

The facts relating to the actions are not disputed in any substantial degree. Arden has been in the business of selling cosmetics, fragrances and beauty treatment products for over seventy years. Department stores constitute the greatest number of outlets for these products. To a limited extent, they are also distributed in prestige drug stores. Arden also distributes its products through its own Elizabeth Arden beauty salons.

During 1981 and 1982, Eli Lilly developed for Arden a revolutionary and highly effective composition for use as a lip treatment cream. There is a patent application pending in the United States Patent and Trademark Office for this composition. In early 1983, Arden began to market the composition as a lip treatment cream called “LIP-FIX creme.” An application to register LIP-FIX is currently pending in the United States Patent and Trademark Office. The principal purpose of the cream is to smooth over wrinkles in the lips to assist the application of lipstick and to prevent its smearing or bleeding.

More than $4 million has been spent to promote the LIP-FIX mark. The LIP-FIX treatment cream has been extensively advertised in print and broadcast media, and more than two million units of LIP-FIX creme have been sold since April 1983 at an initial price to the consumer of $10 a unit.

Arden’s LIP-FIX lip treatment cream is part of Arden’s Visible Difference cosmetics line. The packaging for this line of cosmetics is a distinctive pink, red and gold, featuring the Visible Difference trademark, the Elizabeth Arden name and the descriptive terms of the products, i.e. “eyecare concentrate in a tube,” “eyecare concentrate,” “refining moisture-cream complex,” “special moisture-formula for bodyeare” and “moisture-creme soap.”

Arden modified this packaging somewhat for Visible Difference LIP-FIX creme to draw attention to the new product in the line. The LIP-FIX creme packaging is pink and white with the Visible Difference trademark and the Elizabeth Arden name. The advertising for the product includes a distinctive “before and after” photograph to demonstrate the effectiveness of the product. Arden and Eli Lilly have spent over $4 million in promoting LIP-FIX on television, in print advertising and on the radio. The “LIP-FIX creme” has sold well and its considerable success was duly noted by Revlon.

*481 Revlon is also a major marketer of cosmetic products in a number of different lines. In December, 1980, Revlon introduced a new line of skin treatment products under the trademark European Collagen Complex and the house mark Revlon. Revlon’s European Collagen Complex line features treatment products. The first two products, introduced in December 1980, were an “exceptional beauty cream,” packaged in a jar, and an “exceptional beauty lotion,” packaged in a bottle. Revlon began selling its “exceptional beauty cream” packaged in a tube to department stores in March 1983, and to drug stores and mass volume retailers in August 1983.

Revlon currently intends to add four products to its European Collagen Complex line. Revlon’s European Collagen Complex “body care concentrate” and “refining facial” are scheduled to be shipped to department stores in January 1984 and European Collagen Complex “nourishing cleanser” will be shipped to department stores, drug stores and mass volume retailers in March 1984. The fourth new product, the one at issue in this case, is Revlon’s European Collagen Complex “lip repair cream,” scheduled to be shipped to department stores, drug stores and mass volume retailers on December 12, 1983. At present some $600,000 worth of orders have been received by Revlon. Based on this response, Revlon anticipates $1,720,000 in sales by the end of the year and $4 million in sales by June 1984. The consumer unit price is $6.50.

The containers- for Revlon’s European Collagen Complex “exceptional beauty cream” and “exceptional beauty lotion” are a distinctive combination of taupe and white, with purple lettering and a silver band. Each of these containers bears the European Collagen Complex trademark printed in the same distinctive type style, the Revlon name and the descriptive term for the product, i.e., “exceptional beauty cream” or “exceptional beauty lotion.” The advertising for these products incorporates the color purple and features a distinctive “sequential” photograph of a woman’s face.

The packaging for Revlon’s new European Collagen Complex “nourishing cleanser” and “refining facial” closely resembles the packaging for the existing European Collagen Complex products, “exceptional beauty cream” and “exceptional beauty lotion.” The packaging for European Collagen Complex “body care concentrate” and “lip repair cream” is somewhat different. Both products display the European Collagen Complex trademark in its distinctive type style, the Revlon name and the colors purple, white, silver and taupe, but both display the colors in different combinations.

The “lip repair cream” packaging presents the biggest change. It is predominantly purple and the descriptive term for the product “lip repair cream,” is displayed more prominently than are the descriptive terms for the other products in the line.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

JA Apparel Corp. v. Abboud
591 F. Supp. 2d 306 (S.D. New York, 2008)
Playboy Enterprises, Inc. v. Terri Welles, Inc.
78 F. Supp. 2d 1066 (S.D. California, 1999)
French Transit, Ltd. v. Modern Coupon Systems, Inc.
818 F. Supp. 635 (S.D. New York, 1993)
Shakespeare Co. v. Silstar Corp. of America, Inc.
802 F. Supp. 1386 (D. South Carolina, 1992)
Laureyssens v. Idea Group, Inc.
768 F. Supp. 1036 (S.D. New York, 1991)
United States Shoe Corp. v. Brown Group, Inc.
740 F. Supp. 196 (S.D. New York, 1990)
Coherent, Inc. v. Coherent Technologies, Inc.
736 F. Supp. 1055 (D. Colorado, 1990)
Wonder Labs, Inc. v. Procter & Gamble Co.
728 F. Supp. 1058 (S.D. New York, 1990)
Frito-Lay, Inc. v. Bachman Co.
704 F. Supp. 432 (S.D. New York, 1989)
Elizabeth Taylor Cosmetics Co. v. Annick Goutal, S.A.R.L.
673 F. Supp. 1238 (S.D. New York, 1987)
Banff, Ltd. v. Federated Department Stores, Inc.
638 F. Supp. 652 (S.D. New York, 1986)
Charles of the Ritz Group, Ltd. v. Marcon, Ltd.
635 F. Supp. 158 (S.D. New York, 1986)
Marker International v. deBruler
635 F. Supp. 986 (D. Utah, 1986)
Metro Kane Imports, Ltd. v. Rowoco, Inc.
595 F. Supp. 702 (S.D. New York, 1984)

Cite This Page — Counsel Stack

Bluebook (online)
577 F. Supp. 477, 223 U.S.P.Q. (BNA) 251, Counsel Stack Legal Research, https://law.counselstack.com/opinion/eli-lilly-and-co-v-revlon-inc-nysd-1983.